International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 1 , Pages 71-78 , January 2010

Unacceptable Cosmesis in a Protocol Investigating Intensity-Modulated Radiotherapy With Active Breathing Control for Accelerated Partial-Breast Irradiation

Presented in part at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology, September 21–25, 2008, Boston, MA.

  • Reshma Jagsi, M.D., D.Phil.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
    • Corresponding Author InformationRequests for reprints to: Reshma Jagsi, M.D., Department of Radiation Oncology, University of Michigan, UHB2C490, SPC 5010, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5010. Tel: (734) 936-7810; Fax: (734) 763 7370
    • ,
  • Merav A. Ben-David, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
    • ,
  • Jean M. Moran, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
    • ,
  • Robin B. Marsh, C.M.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
    • ,
  • Kent A. Griffith, M.P.H., M.S.

      Affiliations

    • Biostatistics Unit, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
    • ,
  • James A. Hayman, M.D., M.B.A.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
    • ,
  • Lori J. Pierce, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI

Received 16 June 2008 ,Revised 12 January 2009 ,Accepted 14 January 2009.

References 

  1. Clarke M, Collins R, Darby S. The Early Breast Cancer Trialists Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–2106
  2. Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94:1143–1150
  3. The START Trialists Group. The UK Standardization of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol. In press.
  4. Clark RM, McCulloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992;84:683–689
  5. Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int J Radiat Oncol Biol Phys. 2004;60:722–730
  6. Vicini FA, Kestin L, Chen P, et al. Limited field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205–1211
  7. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol. 2001;12:997–1003
  8. Holland R, Veling S, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast conserving therapy. Cancer. 1985;56:979–990
  9. Vaidya JS, Vyas JJ, Chinoy RF, et al. Multicentricity of breast cancer: Whole organ analysis and clinical implications. Br J Cancer. 1996;74:820–824
  10. Morimoto T, Okazaki K, Komaki K, et al. Cancerous residue in breast-conserving surgery. J Surg Oncol. 1993;52:71–76
  11. Radiation Therapy Oncology Group. RTOG 0413/NSABP B-39 Study Protocol. Available at: http://www.rtog.org/members/protocols/0413/0413.pdf. Accessed May 8, 2008.
  12. Benitez PR, Chen PY, Vicini FA, et al. Partial breast irradiation in breast-conserving therapy by way of interstitial brachytherapy. Am J Surg. 2004;188:355–364
  13. Kuske RR, Bolton JS. A phase I/II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma. Radiation Therapy Oncology Group publication no. 1055. Philadelphia: RTOG; 1995;
  14. Perera F, Chisela F, Engle J, et al. Method of localization and implantation of the lumpectomy site for high dose rate brachytherapy after conservative surgery for T1 and T2 breast cancer. Int J Radiat Oncol Biol Phys. 1995;31:959–965
  15. Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121–128
  16. Formenti SC. External-beam partial breast irradiation. Semin Radiat Oncol. 2005;15:92–99
  17. Cuttino LW, Todor D, Pacyna L, et al. Three dimensional conformal external beam radiotherapy for accelerated partial breast irradiation: What is the correct prescription dose?. Am J Clin Oncol. 2006;29:474–478
  18. Weed DW, Edmundson GK, Vicini FA, et al. Accelerated partial breast irradiation: A dosimetric comparison of three different techniques. Brachytherapy. 2005;4:121–129
  19. Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55:302–311
  20. Frazier RC, Vicini F, Sharpe MB. The impact of respiration on whole breast radiotherapy: A dosimetric analysis using active breathing control (Abstr.). Int J Radiat Oncol Biol Phys. 2000;48:200
  21. Weed DW, Yan D, Martinez AA, et al. The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2004;60:484–492
  22. Kessler ML, McShan DL, Epelman MA, et al. Costlets: A generalized approach to cost functions for automated optimization of IMRT treatment plans. Optimization Engineering. 2005;6:421–448
  23. National Cancer Institute. Common toxicity criteria for adverse events. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed May 8, 2008.
  24. Radiation Therapy Oncology Group. Form COS (06-28-2005). Available at: http://www.rtog.org/members/protocols/0413/0413.pdf. Accessed May 15, 2008.
  25. Ben-David MA, Sturtz DE, Griffith KA, et al. Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: The University of Michigan experience. Breast J. 2007;13:392–400
  26. Ribeiro GG, Dunn G, Swindell R, et al. Conservation of the breast using two different radiotherapy techniques: Interim report of a clinical trial. Clin Oncol. 1990;2:27–34
  27. Ribeiro GG, Magee B, Swindell R, et al. The Christie Hospital breast conservation trial: An update at 8 years from inception. Clin Oncol. 1993;5:278–283
  28. Formenti SC, Rosenstein B, Skinner KA, et al. T1 stage breast cancer: Adjuvant hypofractionated conformal radiation therapy to the tumor bed in selected postmenopausal breast cancer patients—pilot feasibility study. Radiology. 2002;222:171–178
  29. Truong M, Hirsch A, Formenti S. Novel approaches to post operative radiation therapy as part of breast conserving therapy for early stage breast cancer. Clin Breast Cancer. 2003;4:253–263
  30. Formenti SC, Truong MT, Goldberg JD, et al. Prone accelerated partial breast radiation after breast conserving surgery: preliminary clinical results and dose volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004;60:493–504
  31. Vicini FA, Remouchamps V, Wallace M, et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;57:1247–1253
  32. Vicini FA, Chen P, Wallace M, et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2007;69:1124–1130
  33. Kozak KR, Katz A, Adams J, et al. Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys. 2006;65:1572–1578
  34. Kozak KR, Smith BL, Adams J, et al. Accelerated partial breast irradiation using proton beams: Initial clinical experience. Int J Radiat Oncol Biol Phys. 2006;66:691–698
  35. Lacombe MA, McMahon J, Al-Najjar W, et al. Accelerated partial breast irradiation using intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60(1 Suppl. 1):S237–S244
  36. Rusthoven KE, Carter DL, Howell K, et al. Accelerated partial-breast intensity-modulated radiotherapy results in improved dose distribution when compared with three-dimensional treatment-planning techniques. Int J Radiat Oncol Biol Phys. 2008;70:296–302
  37. Livi L, Paiar F, Buonamici FB, et al. Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: A preliminary study. Tumori. 2005;91:227–232
  38. Oliver M, Chen J, Wong E, et al. A treatment planning study comparing whole breast radiation therapy against conformal, IMRT and tomotherapy for accelerated partial breast irradiation. Radiother Oncol. 2007;82:317–323
  39. National Surgical Adjuvant Breast and Bowel Project. Memorandum to NSABP principal investigators and program coordinators from Judy Langer, Regulatory Specialist, NSABP Operations Center. December 21, 2006. Re: NSABP B-39/RTOG 0413 impending closure of accrual to specific populations (second notice). Available at: http://www.rtog.org/members/protocols/0413/B-39%20L-R%20Group%20Closure%20Notice%20Reminder_12-21-06.pdf. Accessed February 6, 2007.
  40. Li C, Wilson P, Levine E. TGF-beta levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer. 1999;84:155–159
  41. Quarmby S, Fakhoury H, Levine E, et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol. 2003;79:137–143

 Supported in part by Grant No. P01 CA598 27 from the National Institute of Health.

 Conflict of interest: none.

PII: S0360-3016(09)00137-0

doi: 10.1016/j.ijrobp.2009.01.041

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 1 , Pages 71-78 , January 2010

Article Tools

* Image Usage & Resolution